Archives

• November/December 2012

  
  November December 2012 Advertorial
  November December 2012 Supplement
  November December 2012 Supplement

• October 2012

  
  October 2012 Advertorial
  October 2012 Advertorial

• September 2012

  
  September 2012 Digital Supplement
  September 2012 Digital Supplement

• July/August 2012

  
  July August 2012 Supplement

• May 2012

  
  May 2012 Insert
  May 2012 Supplement

• April 2012

  

• March 2012

  Feature Story Intravitreal Aflibercept for AMD: 2-year Results By Jeffery S. Heier, MD
  March 2012 Advertorial

• January/February 2012

  Feature Story Curved Scissors Delamination By STEVE CHARLES, MD, FACS, FICS
  January February 2012 Supplement

TOP 5 ARTICLES FROM 2012

• Treatment of Retinal Vein Occlusion

  Individualized therapy is crucial to good patient outcomes.

  By Gaurav K. Shah, MD

• Intravitreal Aflibercept for AMD: 2-year Results

  The VIEW 1 and 2 studies showed high degrees of safety and efficacy at 2 years.

  By Jeffery S. Heier, MD

• Treatment of Vitreomacular Adhesion: Present Status, Future Prospects

  The technology is already in use for diagnosis and management of some conditions.

  By J. Sebag, MD, FACS, FRCOphth, FARVO

• Ocular Drug Delivery Systems for the Posterior Segment: A Review

  By Noriyuki Kuno, PhD; and Shinobu Fujii

• A New Focus on the Vitreous and Its Role in Retinal Function

  By Pravin U. Dugel, MD